Upadacitinib is not approved for pediatric IBD, though the selective JAK1 inhibitor is indicated for patients 2 years and older with juvenile idiopathic arthritis and psoriatic arthritis. The findings ...
When I was in the throes of cancer treatment and so miserable with nausea and the lower GI’s, I ran across this aphorism: “What Cancer Cannot Do! Cancer is so limited…It cannot cripple Love; It cannot ...
ATH-063 is a novel, oral, first-in-class, small molecule therapeutic targeting both inflammation and direct mucosal healing ...
A "living glue" used by barnacles to attach to underwater surfaces could also seal gut wounds caused by inflammatory bowel ...
Background IBD is characterised by recurrent flares, but evidence on whether modifiable dietary factors influence flare risk ...
Regular stool tests already used in NHS care, combined with dietary information, could help identify people with inflammatory bowel disease (IBD) at higher risk of relapse, a major study suggests.
The response to first advanced treatment initiated is significantly associated with a lower long-term risk for hospitalization.
Real-world data show distinct determinants of health-related quality of life in Crohn’s disease and ulcerative colitis, ...
Everyday Health on MSN
How to ease ulcerative colitis symptoms during a flare
Ease the symptoms of a UC flare, such as diarrhea, abdominal pain, and fever using expert-backed tips, and learn when to seek ...
The Crohn's & Colitis Foundation’s Georgia Chapter is pleased to host its 35th Annual Torch Gala at the InterContinental Buckhead Atlanta, on February 7, 2026. The goal: to raise $850,000 through the ...
In January 2022, Garutadustat, the innovative, potentially best-in-class, oral PHD inhibitor was nominated as a preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results